Depression in patients with ankylosing spondylitis
Rheumatology & Autoimmunity · 2022-06 · 2 (2) · 69-75
DOI: 10.1002/rai2.12020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology & Autoimmunity, online erschienen am 24.04.2022. Verfasst von Tianjiao Ma und 2 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Depression
Abstract (Originalsprache)
Ankylosing spondylitis (AS) is a chronic inflammatory spondyloarthropathy that can cause severe physical and functional damage. The risk of depression is higher in AS patients than in the general population. Depression in AS patients affects disease prognosis and is receiving greater attention. By mining the literature on depression in AS patients in China and other countries, we analyzed research gaps and flaws in this area. In this review, we describe current knowledge regarding depression status, pathogenesis, disease relevance, and treatment of depression in AS patients. The findings may help to prevent depression, improve treatment, and enhance chronic disease management in AS patients.
Zitieren
APA
Ma, T., Geng, Y., & Li, P. (2022). Depression in patients with ankylosing spondylitis. Rheumatology & Autoimmunity, 2(2), 69-75. https://doi.org/10.1002/rai2.12020
Vancouver
Ma T, Geng Y, Li P. Depression in patients with ankylosing spondylitis. Rheumatology & Autoimmunity. 2022;2(2):69-75. doi:10.1002/rai2.12020
BibTeX
@article{Ma2022,
author = {Ma, Tianjiao and Geng, Yingying and Li, Ping},
title = {Depression in patients with ankylosing spondylitis},
journal = {Rheumatology & Autoimmunity},
year = {2022},
volume = {2},
number = {2},
pages = {69--75},
doi = {10.1002/rai2.12020}
}
EUVIMED